Genetic downregulation of receptor-interacting protein 140 uncovers the central role of Akt signalling in the regulation of fatty acid oxidation in skeletal muscle cells

Experimental Physiology

Volumn 98, Issue 2, 2013, Pages 514-525

  Constantinescu, Silvana ^a   Turcotte, Lorraine P ^a,b  

^a Human and Evolutionary Biology Section   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CARNITINE PALMITOYLTRANSFERASE I; CYTOCHROME C OXIDASE; FATTY ACID TRANSPORTER; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; INSULIN; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; PROTEIN KINASE C; RECEPTOR INTERACTING PROTEIN 140;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION; METABOLIC REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 84872687809     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.068833     Document Type: Article

References (36)

1. Bogachus LD & Turcotte LP (2010). Genetic downregulation of AMPK-α isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Am J Physiol Cell Physiol 299, C1549-C1561.
2. Bonen A, Chabowski A, Luiken JJFP & Glatz JFC (2007). Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology 22, 15-28.
3. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R & Dela F (2007). Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50, 790-796.
4. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A & Zierath JR (2006). siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4, 89-96.
5. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ & Hawley JA (2003). Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88, 5444-5451.
6. Diaz MB, Herzig K-H, Metzger D, Ziegler A, Vegiopoulos A, Klingenspor M, Müller-Decker K & Herzig S (2008). Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice. Hepatology 48, 782-791.
7. Dyck DJ, Peters SJ, Glatz JFC, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, Van der Vusse GJ & Bonen A (1997). Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol Endocrinol Metab 272, E340-E351.
8. Dyck DJ, Steinberg G & Bonen A (2001). Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle. Am J Physiol Endocrinol Metab 281, E600-E607.
9. Frier BC, Hancock CR, Little JP, Fillmore N, Bliss TA, Thomson DM, Wan Z & Wright DC (2011). Reductions in RIP140 are not required for exercise- and AICAR-mediated increases in skeletal muscle mitochondrial content. J Appl Physiol 111, 688-695.
10. Fritah A (2009). Control of skeletal muscle metabolic properties by the nuclear receptor corepressor RIP140. Appl Physiol Nutr Metab 34, 362-367.
11. Hancock CR, Han DH, Terada S, Yasuda T, Wright DC & Holloszy JO (2008). High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci USA 105, 7815-7820.
12. Ho PC, Lin YW, Gupta P & Wei LN (2009). A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160. Cell Metab 10, 516-523.
13. Holloway GP, Luiken JFP, Glatz JFC, Spriet LL & Bonen A (2008). Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview. Acta Physiol (Oxf) 194, 293-309.
14. Irving BA, Short KR, Nair KS & Stump CS (2011). Nine days of intensive exercise training improves mitochondrial function but not insulin action in adult offspring of mothers with type 2 diabetes. J Clin Endocrinol Metab 96, E1137-E1141.
15. Izadpanah A, Barnard RJ, Almeda AJ, Baldwin GC, Bridges SA, Shellman ER, Burant CF & Roberts CK (2012). A short-term diet and exercise intervention ameliorates inflammation and markers of metabolic health in overweight/obese children. Am J Physiol Endocrinol Metab 303, E542-E550.
16. Kelly KR, Sung CK, Abbott MJ & Turcotte LP (2008). Phosphatidylinositol 3-kinase-dependent insulin regulation of long-chain fatty acid (LCFA) metabolism in L6 cells: involvement of atypical protein kinase C-ζ in LCFA uptake but not oxidation. J Endocrinol 198, 375-384.
17. Kiens B (2006). Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86, 205-243.
18. Kim J, Wei Y & Sowers JR (2008). Role of mitochondrial dysfunction in insulin resistance. Circ Res 102, 401-414.
19. Liu H-Y, Hong T, Wen G-B, Han J, Zuo D, Liu Z & Cao W (2009). Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. Am J Physiol Endocrinol Metab 297, E898-E906.
20. Lowell BB & Shulman GI (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387.
21. Luiken JJFP, Koonen DPY, Willems J, Zorzano A, Becker C, Fischer Y, Tandon NN, Van der Vusse GJ, Bonen A & Glatz JFC (2002). Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51, 3113-3119.
22. Luiken JJFP, Ouwens DM, Habets DDJ, van der Zon GCM, Coumans WA, Schwenk RW & Glatz JFC (2009). Permissive action of protein kinase C-ζ in insulin-induced CD36- and GLT4 translocation in cardiac myocytes. J Endocrinol 201, 199-209.
23. Meng RS, Pei ZH, Yin R, Zhang CX, Chen BL, Zhang Y, Liu D, Xu AL & Dong YG (2009). Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-α signaling pathway. Eur J Pharmacol 620, 63-70.
24. Menshikova EV, Ritov VB, Toledo FGS, Ferrell RE, Goodpaster BH & Kelley DE (2005). Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288, E818-E825.
25. Mogenstein DL & Parker MG (2007). Role of nuclear receptor coregulators in metabolism. Expert Rev Endocrinoo Metab 2, 797-807.
26. Muoio DM (2010). Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused Biochim Biophys Acta 1801, 281-288.
27. Palou M, Priego T, Sánchez Z, Villegas E, Rodríguez AM, Palou A & Picó C (2008). Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting. Pflugers Arch 456, 825-836.
28. Pei L, Castrillo A & Tontonoz P (2006). Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 20, 786-794.
29. Powelka AM, Seth A, Virbasius JV, Kiskinis E, Nicoloro SM, Guilherme A, Tang X, Straubhaar J, Cherniack AD, Parker MG & Czech MP (2006). Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J Clin Invest 116, 125-136.
30. Rabol R, Boushel R & Dela F (2006). Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 31, 675-683.
31. Rimbert V, Vidal H, Duché P, Debard C, Giraudet C, Boirie Y, Chardigny J-M & Morio B (2009). Rapid down-regulation of mitochondrial fat metabolism in human muscle after training cessation is dissociated from changes in insulin sensitivity. FEBS Lett 583, 2927-2933.
32. Scarpulla RC (2006). Nuclear control of respiratory gene expression in mammalian cells. J Cell Biochem 97, 673-683.
33. Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, Fritah A, Mobberley M, Ryder TA, Rowlerson A, Scott J, Poutanen M, White R & Parker M (2007). The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab 6, 236-245.
34. Simoneau J & Kelley DE (1997). Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83, 166-171.
35. Turcotte LP (2006). Skeletal muscle lipid metabolism during exercise. In Exercise Metabolism, ed. Hargreaves M. & Spriet L, pp. 105-135. Human Kinetics, Inc., Champaign, IL .
36. Zschiedrich I, Hardeland U, Krones-Herzig A, Berriel DM, Vegiopoulos A, Müggenburg J, Sombroek D, Hofmann TG, Zawatzky R, Yu X, Gretz N, Christian M, White R, Parker MG & Herzig S (2008). Coactivator function of RIP140 for NFκB/RelA-dependent cytokine gene expression. Blood 112, 264-276.